RecruitingPhase 2NCT05610085

A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Diego
Principal Investigator
Sonya G Wang, M.D., M.D
University of Minnesota
Intervention
Levetiracetam Injection(drug)
Enrollment
133 target
Eligibility
All sexes
Timeline
20232027

Study locations (5)

Collaborators

University of Minnesota · Rady Children's Hospital, San Diego · Auckland City Hospital · University of Auckland, New Zealand · Middlemore Hospital, New Zealand

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05610085 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials